NASDAQ:BVXV
Delisted

Biondvax Pharmaceuticals Stock News

etoro logo Buy BVXV
*Your capital is at risk
$1.36
+0 (+0%)
At Close: Dec 05, 2023
JERUSALEM, Oct. 7, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (BVXV), a phase 3 clinical stage biopharmaceutical company focused on developing and commercializing the M-001 clinical Phase 3 Un
JERUSALEM , Aug. 28, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a Phase 3 clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal
On July 16, 2019, BiondVax Pharmaceuticals Ltd. (BVXV) announced that the previously announced rights offering was fully subscribed and the company raised gross proceeds of $20 million through the sal
JERUSALEM, Israel, July 16, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (BVXV) is proud to announce today the results of its previously announced rights offering. The Company has received sub
JERUSALEM, July 8, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (BVXV) announced today that the first participants in the second cohort of the pivotal, clinical efficacy, Phase 3 trial of the
JERUSALEM, June 26, 2019 /PRNewswire/ -- The Board of Directors and Management of BiondVax Pharmaceuticals Ltd. (BVXV), was honored to host Mr. Ambroise Fayolle, Vice-President of the European Investm
BiondVax Pharmaceuticals Ltd. (BVXV) secured a grant from the Israel Investment Center, a unit of the Government of Israel's Ministry of Economy and Industry, to build a manufacturing facility for th
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE